Detecting a modification rather than a protein: why a ubiquitin antibody, an anti-ubiquitin antibody and a ubiquitination antibody are three product descriptions for reagents that differ in what chain linkage they see, what a ubiquitin western blot looks like when it works and why a smear is the expected result rather than a failure, how sample preparation has to inhibit the enzymes that remove the modification before lysis, and what controls separate a real modification signal from a loading artefact

Getting a modification blot to work

1. Inhibit the removing enzymes at lysis. Deubiquitinases, phosphatases and other erasers remain active in a cold lysate and strip the modification within minutes. The inhibitor has to be in the buffer before the cells meet it, not added afterwards.
2. Choose the reagent by linkage and by state. Some antibodies recognise the modifier regardless of context, some recognise a specific chain linkage, and some recognise the modified form of one target protein. These answer different questions and are frequently sold under similar names.
3. Expect a distribution, not a band. Poly modified proteins run as a ladder or a smear because chain length varies. A clean single band from a general reagent is more likely to be a cross reaction than a result.
4. Enrich when the fraction is small. Only a small proportion of a target is usually modified at any moment. Immunoprecipitation of the target followed by modification blotting, or capture with a binding domain reagent, is often the only way to see it.
5. Control with a treatment that changes the modification. An inhibitor or stimulus that raises or lowers the modification is the control that proves the signal is the modification. An untreated lane alone proves nothing about specificity.
6. Record the clone and the lysis buffer together. For this class of reagent the buffer is as much part of the method as the antibody. Keep them recorded as a pair, because a protocol that omits the inhibitor cocktail will not reproduce.

The buffer is half the reagent

For modification detection, what happens in the first two minutes of lysis determines whether there is anything to detect. Inhibitors in the buffer, cold everything, and a short path from plate to denaturation are the whole technique.

Laboratories that standardise a single modification lysis buffer, made fresh with inhibitors and dated, stop having this class of failure almost entirely.

Validating a modification antibody

The strongest validation is a treatment that moves the modification in a known direction, ideally in both directions, with the total protein unchanged. Genetic removal of the modification site is stronger still where it is feasible.

A supplier's blot on an overexpressing lysate is not validation for your system. Run the treatment control once per clone and keep the image with the reagent record.

Common questions

Why is my modification blot a smear?

Because chain length and site occupancy vary across the population, which produces a distribution rather than a band. For poly modified targets that smear is the correct result and quantifying it means integrating the region rather than picking a band.

Why did the signal disappear?

Almost always active removing enzymes during lysis. The inhibitor must be present in the buffer before lysis, samples kept cold and processing kept short. Warm handling for a few minutes is enough to lose the signal.

Do I need a linkage specific reagent?

Only if the linkage is the question. For a general question about whether a target is modified, a pan reagent with a good enrichment step is usually the practical route, with a linkage specific reagent to follow up.

Can I strip and reprobe for the total protein?

It is common and it is risky, because stripping removes target as well as antibody. A duplicate membrane or fluorescent multiplexing gives a more defensible total protein comparison.

Browse by service class

• Compare Gene synthesis on advertised prices